Additional information
Free Base-112110-48-2
White Powder
NA
ACI-023404
66.1-67.0°C
C24H35ClN2O5
467
2-8°C
Antidiabetic
Pharmaceutical Impurity Standards
(3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
(3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
1H-1-Benzazepine-1-acetic acid, 3-[[3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]-2,3,4,5-tetrahydro-2-oxo-, [S-(R*,R*)]





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)